cirrhosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver injury, often due to alcohol use or viral hepatitis, leads to repeated cycles of liver cell damage and repair, resulting in the replacement of healthy liver tissue with fibrotic scar tissue. This fibrosis disrupts normal liver architecture, compromising its ability to function effectively.

• Secondary mechanism: The buildup of scar tissue increases intrahepatic vascular resistance, causing portal hypertension. This pressure elevation in the portal vein system leads to complications such as variceal bleeding and ascites, as blood flow is redirected to collateral circulations.

• Key complication: Hepatocyte dysfunction and portal hypertension contribute to decreased synthesis of essential proteins like albumin and clotting factors, as well as impaired detoxification processes, resulting in complications such as coagulopathy, jaundice, and hepatic encephalopathy.

Patient Profile

Demographics:

56 years old, male, construction worker

History:

• Key past medical history: Chronic alcohol use, Hepatitis C infection, hypertension

• Current medications: Lisinopril, Lactulose, Spironolactone

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Abdominal swelling and discomfort

• Key symptoms: Jaundice, fatigue, peripheral edema, confusion

• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 20 breaths/min, temperature 37.5°C, oxygen saturation 94% on room air

Section 1

As the care team proceeds with the initial assessment, the patient's abdominal discomfort is further evaluated. The physical examination reveals significant ascites, indicated by a distended abdomen and positive fluid wave test. Peripheral edema is noted in the lower extremities, consistent with the patient's reported swelling. The presence of spider angiomas on the patient's chest and upper limbs, along with palmar erythema, suggest chronic liver disease. Furthermore, the patient exhibits asterixis, a clinical sign of hepatic encephalopathy, which aligns with the reported confusion. These findings, coupled with the jaundice and fatigue, underscore the extent of liver dysfunction.

Laboratory results return, providing critical insights into the patient's condition. The liver function tests show elevated bilirubin levels at 4.2 mg/dL and transaminases with an AST of 112 U/L and ALT of 78 U/L, indicating hepatocellular injury. The albumin level is notably low at 2.5 g/dL, reflecting impaired synthetic function of the liver. Coagulation studies reveal an elevated International Normalized Ratio (INR) of 1.9, suggesting compromised production of clotting factors. The ammonia level is elevated at 85 µmol/L, corroborating the diagnosis of hepatic encephalopathy.

Given these findings, the team prioritizes interventions to manage the ascites and hepatic encephalopathy. Spironolactone is titrated to address fluid retention, while lactulose dosing is optimized to reduce ammonia levels. The patient is also educated on dietary modifications, including sodium restriction, to further manage ascites. Close monitoring of mental status and regular assessments of vital signs and laboratory parameters will guide ongoing treatment and adjustment of medications. The team remains vigilant for further complications, such as variceal bleeding, given the portal hypertension, and prepares to initiate additional interventions as needed.

Section 2

As the care team continues to monitor the patient, a change in status is observed. The patient begins to experience increasing shortness of breath and a decrease in oxygen saturation, dropping to 90% on room air. Upon auscultation, diminished breath sounds are noted at the lung bases, which suggests pleural effusion, a potential complication of ascites. The patient's respiratory rate increases to 24 breaths per minute, and there is a mild use of accessory muscles, indicating respiratory distress. Given these findings, a chest X-ray is ordered, confirming the presence of a moderate right-sided pleural effusion.

Additionally, the patient's abdominal girth has increased despite adherence to the sodium-restricted diet and spironolactone therapy. The care team decides to perform a therapeutic paracentesis to relieve the pressure and improve respiratory function. During the procedure, approximately 3 liters of straw-colored fluid are removed, leading to an immediate improvement in the patient's breathing and oxygen saturation, which increases to 94% on room air. The fluid is sent for analysis to evaluate for infection, such as spontaneous bacterial peritonitis (SBP), a known risk in cirrhotic patients with ascites.

As the day progresses, the patient's mental status is closely monitored for signs of hepatic encephalopathy. Although initially improving, the patient suddenly becomes more lethargic and disoriented, struggling to follow simple commands. A quick bedside assessment reveals asterixis persists, and repeat ammonia levels remain elevated at 92 µmol/L despite lactulose therapy. The team considers adding rifaximin as an adjunct treatment to further reduce ammonia-producing intestinal bacteria. The patient's family is updated on the situation, and the team works to prevent further complications by reviewing medication adherence, dietary intake, and closely monitoring laboratory values. This change in the patient's status underscores the complexity of managing cirrhosis and highlights the need for vigilant, ongoing assessment and timely intervention.

Section 3

As the care team continues to monitor the patient's condition, new diagnostic results provide additional insight into the complexities of the case. The analysis of the ascitic fluid obtained during the paracentesis returns with a white blood cell count of 350 cells/mm³, predominantly neutrophils, indicating an elevated risk for spontaneous bacterial peritonitis (SBP). In response, the team initiates empirical antibiotic therapy with intravenous cefotaxime, while awaiting culture results to confirm the presence of bacterial infection. Blood cultures are also drawn to further assess for systemic infection, given the patient's cirrhotic state and increased vulnerability to bacterial translocation.

Simultaneously, the most recent liver function tests reveal a concerning trend, with serum bilirubin rising to 3.5 mg/dL, and the international normalized ratio (INR) extending to 1.8, suggesting worsening synthetic liver function. The patient's albumin level has decreased to 2.8 g/dL, which correlates with the ongoing ascites and potential nutritional deficiencies. These findings necessitate a reassessment of the patient's nutritional plan, and a dietitian is consulted to optimize protein intake while maintaining sodium restrictions.

As the day progresses, the patient's mental state fluctuates. Despite the initiation of rifaximin alongside lactulose, the patient's ammonia levels remain elevated, and their orientation is inconsistent. The care team prioritizes frequent neurological assessments to catch any further decline promptly. Meanwhile, the family is counseled on signs of worsening hepatic encephalopathy they should report immediately. The team also evaluates the patient's medication regimen for potential nephrotoxic agents or sedatives that could exacerbate encephalopathy. With these developments, the focus remains on stabilizing the patient's condition while preventing further deterioration through vigilant monitoring and timely intervention. The evolving clinical picture emphasizes the importance of an interdisciplinary approach in managing the multifaceted challenges of cirrhosis.

Section 4

As the care team continues to manage the patient with cirrhosis, a new complication emerges. The patient begins to exhibit signs of renal dysfunction, a concern given their increased vulnerability to hepatorenal syndrome. Urine output has significantly decreased over the past 12 hours, dropping to less than 400 mL, and the patient's creatinine level has risen to 2.0 mg/dL from a baseline of 1.2 mg/dL. These findings prompt the team to initiate a fluid resuscitation strategy with intravenous albumin, aiming to improve renal perfusion and halt the progression of renal impairment. The potential for hepatorenal syndrome underscores the critical need for careful fluid management and monitoring of renal function.

In parallel, the patient's respiratory status is also under scrutiny. The patient has developed mild dyspnea and a low-grade fever of 100.4°F (38°C), raising concerns about possible pulmonary complications such as hepatic hydrothorax or an infection like pneumonia, secondary to their compromised immune state. A chest X-ray is ordered, revealing a small right-sided pleural effusion. The team decides to closely observe the patient's respiratory status, ensuring adequate oxygenation and considering the need for thoracentesis if symptoms worsen. The possibility of translocation-related infections is kept in mind, and broad-spectrum antibiotics are continued pending culture results.

Throughout these developments, the interdisciplinary team remains focused on stabilizing the patient's condition, emphasizing the importance of early detection and intervention. Nursing staff are vigilant in monitoring vital signs, renal output, and cognitive status, while maintaining open communication with the family about the implications of these new complications. The care plan is adjusted to address the patient's evolving needs, ensuring that the patient receives comprehensive, holistic care. This approach is pivotal in managing the complex interplay of cirrhosis-related complications, ultimately guiding future interventions in the patient's journey.

Section 5

As the care team continues to monitor the patient closely, new diagnostic results reveal further insights into the developing complications. A repeat chest X-ray conducted 24 hours later shows an increase in the size of the right-sided pleural effusion, now moderate in volume, which correlates with the patient's worsening dyspnea. Arterial blood gas analysis indicates mild respiratory alkalosis with a pH of 7.47, PaCO2 of 33 mmHg, and PaO2 of 70 mmHg, reflecting increased respiratory effort and potential hypoxemia. The patient's oxygen saturation has decreased to 92% on room air, prompting the team to initiate supplemental oxygen therapy at 2 L/min via nasal cannula to maintain adequate oxygenation levels.

In parallel, the patient's renal function continues to be a focal point of concern. Despite the administration of intravenous albumin, the patient's urine output remains low at 300 mL over the past 12 hours, and creatinine levels have further increased to 2.3 mg/dL. Blood urea nitrogen (BUN) has also risen to 45 mg/dL from a previous level of 38 mg/dL, indicating worsening renal insufficiency. The team discusses the potential progression to hepatorenal syndrome type 1, characterized by rapid deterioration in renal function. A nephrology consult is requested to explore further management options, including the potential use of vasoconstrictive agents, to support renal perfusion.

These developments highlight the critical need for dynamic clinical reasoning as the team evaluates and adjusts the care plan. The interdisciplinary team remains vigilant in monitoring the patient's vital signs and laboratory values, ensuring timely interventions to mitigate further complications. Open communication with the patient and family is maintained to provide updates on the patient's condition and to discuss the potential implications of the evolving clinical picture. This proactive approach underscores the importance of comprehensive management in navigating the complexities of cirrhosis and its associated complications.